A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors

• 期刊名称Clinical Cancer Research
• 作者Venugopal, B.; Baird, R.; Kristeleit, R. S.; Plummer, R.; Cowan, R.; Stewart, A.; Fourneau, N.; Hellemans, P.; Elsayed, Y.; Mcclue, S.; Smit, J. W.; Forslund, A.; Phelps, C.; Camm, J.; Evans, T. R. J.; de Bono, J. S.; Banerji, U.
• 卷第19卷
• 期第15期
• 印刷ISSN1078-0432
• 电子ISSN1557-3265
• 文件大小652.35KB
• 发表时间2013-08-01
• DOI10.1158/1078-0432.CCR-13-0312
• 页码4262-4272